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There has recently been an exponential rise in the use of biomaterials, to improve the biocompatibility and targeting of nanomedicines for diagnostic and 
therapeutic intervention. This has become possible through better understanding of the biochemical, cellular and tissue makeup within the diseased 
microenvironment. Eminent scientists, medical practitioners and international experts from over 30 countries from around the globe gathered at the 4th 
International Conference on Nanotechnology in Medicine (NANOMED16)  http://www.nanomed.uk.com/   to discuss the latest advancements in the field of 
Nanomedicine. The conference was held at the Warsaw University of life sciences (WULS), Warsaw, Poland, in November 2016, marking the 200th 
anniversary since its inauguration (WULS-SGGW).  The purpose of this special issue is to share a selection of key studies discussed at the conference, with a 
particular aim of highlighting some of the advances in biomaterial design and application for medical intervention, including tissue-engineering applications.   
 
In the first manuscript, Chan and Hsiao, from the Kaohsiung Medical University in Taiwan, illustrate how understanding the tumour microenvironment, has 
enabled the design of innovative protease activated nanomaterials for successful theranostic targeting. In their special report, they describe the design and 
application of nanomaterials such as graphene oxide and gold nanoparticles labelled with matrix metalloprotein-2 sensing peptides for targeted cancer 
therapy. Other attractive strategies for targeted drug delivery and theranostics include the use of biomimetic peptides for the surface modification of 
nanomaterials. For example, by taking advantage of the overexpression of the folate receptor in many types of human cancers, Justyna Fraczyk and 
colleagues from Zbigniew Kaminski’s group in Lodz, used a biomimetic peptide linker (that is resistant to proteolytic degradation), to modify the surface of 
multiwalled carbon nanotubes (MWCNTs), functionalised with folic acid, for targeted delivery to cancer cells. Ewa Dluska’s group from the Warsaw 
University of Technology utilised a novel emulsion-based drug delivery platform and a pH-responsive biopolymer, to modulate the release of doxorubicine, 
a potent anticancer drug. 
In imaging diagnostics, a number of research groups at the conference show-cased their work on the use of biomaterials for improving the biocompatibility 
and efficacy of contrast agents. In particular, Netti and Torino’s group, from the Centre for Advanced Biomaterials for Healthcare, Italian Institute of 
technology, Napoli, presented a number of studies expected to make clinical impact in the near future. In this special issue, Ponsiglione and colleagues, 
describe the effect of hydration of the hydrogel structure/biopolymer matrices, termed ‘Hydrodenticity’ to improve the relaxometric properties of Gd-DTPA 
contrast agents used in MRI imaging.  Russo and colleagues describe the use of a one-step microfluidic flow focusing approach for the controlled synthesis 
and simultaneous PEGylation and loading of cross-linked hyaluronic acid nanoparticles (cHANPs) for theranostic applications. This approach is attractive 
because it offers a number of advantages including improved reproducibility and the boosting of MRI signal, over traditional processes. Another attractive 
strategy in imaging diagnostics is the combination of several imaging modalities for the simultaneous acquisition of different data to enable early and more 
accurate diagnosis of disease. Indeed, Vecchioni and colleagues, describe a modified coacervation and double cross-linking process for the production of 
hybrid core-shell polymeric nanocarrier system to improve the relaxometric properties, for simultaneous PET/MRI acquisitions, as multimodal imaging 
applications.  
Finally, in tissue engineering, improved understanding of the cellular microenvironment and tissue topography and has allowed researchers to investigate 
the use of nanomaterials for improved biocompatibility and functionality of medical implants. In particular, there is increased interest in new and ‘smart 
materials’ which possess unique properties that resemble those of native tissues. Such materials include ‘Nitinol’, a nickel titanium alloy, which possesses a 
shape memory effect. This is described by Justyna Witkowska’s group, who utilised a hybrid process to enhance the surface properties NiTi shape memory 
alloy, thus making it suitable for cardiovascular applications. Cao and colleagues, demonstrate how the use of nitrogen ion implantation of 3D self-assembly 
graphene scaffolds, improves hydrophilicity, and cyto-compatibility, to support the growth of mouse fibroblast cell, thus making it attractive for tissue 
engineering applications. The last manuscript in this special issue is presented by Sun and colleagues, who highlight the advantages of depositing nanoscale 
TiN/Ag multilayers on the mechanical, cell adhesion, and antibacterial properties of medical implants. The synthesis of such multifunctional layers will 
undoubtedly enable the successful future use of medical devices and implants for improved medical intervention. 
 
